A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Novavax can ...

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual restrictions. Novavax makes the nation’s only traditional protein-based coronavirus ...

There may soon be another COVID-19 vaccine on the market in the U.S. Novavax announced Monday that it has submitted a request to the Food and Drug Administration for emergency use authorization for ...

US health regulators have given final approval to Novavax's COVID vaccine after an unusual delay and have placed new restrictions on the jab, the pharmaceutical company announced Monday. The US drug ...

Novavax (NVAX) has completed the transfer of the marketing authorization for its COVID-19 vaccine, Nuvaxovid to Sanofi (SNY), in the European Union enabling Sanofi to take full responsibility for ...

Novavax (NASDAQ:NVAX) has received regulatory approval in Japan for its COVID-19 vaccine, Nuvaxovid, which has resulted in a milestone payment from Takeda (NYSE:TAK) (OTCPK:TKPHF), the company said on ...

The JN.1 Novavax vaccine is an alternative to the LP.8.1 Pfizer-BioNTech and Moderna vaccines that were rolled out in October.

An additional dose can increase protection against severe disease, CDA said. Read more at straitstimes.com. Read more at ...